Amgen Inc.'s new CEO Robert A. Bradway, who took the helm of the biotechnology giant in May, nearly doubled his salary last year. Bradway, who was promoted to chief executive from chief operating officer on May 23, saw his compensation rise to $13.6 million from $7.1 million in 2011, according to an Associated Press analysis of a company regulatory filing Last year, Bradway, 50, was paid a salary of $1.26 million and received stock awards worth $8.57 million, incentive payments of $3.32 million and miscellaneous compensation totaling $420,059. That included nearly $314,000 in retirement plan contributions, $65,000 for personal use of company aircraft, more than $20,000 for his personal expenses and those of guests during business travel, and $15,000 for financial planning services. Amgen, the world’s biggest biotech company by revenue, reported the figures Monday in a proxy statement filed with the Securities and Exchange Commission ahead of Amgen’s annual meeting on May 22.
